Close this search box.
Subscriber Log In


Catch up with our insights on the big issues in pharma.

Our thought leadership library brings you our latest data-driven reports, infographics and articles that tackle the big issues, interesting niches and everything in between.

Latest Content

Antibody Drug Conjugates Report
Antibody-drug conjugates (ADCs) are the hottest real estate in oncology, attracting billions from big pharma: Pfizer acquired Seagen for $43 billion AbbVie invested over $10 billion in ImmunoGen Merck committed $4 billion upfront, with a potential total...
Read More
Galen Growth: Digital Health 2023 Year End Report
In 2023, the digital health ecosystem witnessed notable consolidation, increased investor scrutiny and a decline in investor support. Health systems prioritised operational efficiency and big tech made strategic investments in emerging AI capabilities. This...
Read More
2023 Review: Don't Look Back in Anger
Most in the biopharma industry would prefer to leave 2023 in the rearview mirror. Before we forge ahead, though, it’s valuable to reflect on how this challenging year closed out. Our 2023 Review covers the good, the bad and the ugly as we ask: Has the...
Read More
More content

Featured Contributors